Related Experiment Video
Updated: Jun 8, 2025
An Experimental Analysis of Children's Ability to Provide a False Report about a Crime
Published on: May 3, 2016
HyperChildNET COST Action CA19115: report of the task force
E Lurbe1,2, G Mancia3, D Drozdz4
1CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
Insights
High blood pressure (BP) in children and adolescents is a critical life course problem. The HyperChildNET initiative established a European network to address this issue and develop new strategies.
Area of Science:
- Pediatric Cardiology
- Public Health
- Cardiovascular Research
Background:
- Cardiovascular disease is a leading global cause of death, with high blood pressure (BP) as a significant modifiable risk factor.
- High BP is increasingly recognized as a life course problem, with adverse outcomes often originating in childhood and adolescence.
- Despite its early onset, high BP in pediatric populations receives limited research attention.
Purpose of the Study:
- To establish a sustainable, multidisciplinary European network focused on high BP in children and adolescents.
- To foster collaboration among researchers, clinicians, policymakers, and industry stakeholders.
- To gain a holistic understanding of factors contributing to high BP in young individuals.
Main Methods:
- Initiated by the European Society of Hypertension (ESH) Guidelines Task Force for children and adolescents.
- Secured funding for the HyperChildNET COST Action program, spanning four years from October 2020.
- Assembled a diverse network including researchers, clinicians, health economists, and industry representatives.
Main Results:
- Successfully established a European multidisciplinary network under the European Commission.
- Facilitated a comprehensive understanding of factors influencing high BP in children and adolescents.
- Laid the groundwork for proposing and implementing preventive and corrective actions.
Conclusions:
- HyperChildNET provides a crucial European perspective on pediatric high BP.
- The initiative creates opportunities for developing novel strategies and future research objectives.
- Addressing high BP in early life is essential for long-term cardiovascular health.
Abstract:
Purpose: Despite dramatic medical advances over the last few decades, cardiovascular disease remains a leading cause of death globally. High BP is clearly established, but modifiable, risk factor for early disability and death. Although most of the adverse outcomes occur in adulthood it has become clear that high BP is a life course problem that can become evident in early life however, relatively little attention has been paid to the problem of high BP in children and adolescents. Materials and methods: Being aware of the problem and the needs, the Task Force of the ESH Guidelines in children and adolescents took the initiative to move forward in the field, identifying the COST Action program. A proposal, HyperChildNET, was submitted, approved and funded for 4 years starting in October 2020. Results: The aim of the Action has been to establish a European sustainable and multidisciplinary network of researchers, clinicians, early career investigators, health economists, decision-makers, regulatory bodies, and medical devices manufacturers under the umbrella of the European Commission in order to acquire a holistic understanding of those factors affecting high BP in children and adolescents in order to propose and implement preventive and corrective actions. All the activities carried out during the 4 years are described. Conclusions: HyperChildNET offers a European perspective of the issue giving us the opportunity to develop new strategies and objectives moving forward in the field.
More Related Videos
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
Related Concept Videos
01:30Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
01:28Conduct Disorder
02:04Bullying